Renalytix plc

Ownership Transactions Reported by 14 Insiders

Symbol
RNLX on Nasdaq, RTNXF on OTC
Industry
Services-Medical Laboratories
Location
Finsgate, 5 7 Cranwood Street, London, United Kingdom

There are no Buy or Sell transactions made by insiders since 7/5/2023

Renalytix plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Icahn School Of Medicine At Mount Sinai 10%+ Owner $4.83 M Apr 24, 2024
Christopher Mills Director, 10%+ Owner $2.52 M Nov 20, 2023
James Renwick McCullough Chief Executive Officer, Director $687 K Jul 6, 2023
O. James Sterling Chief Financial Officer $451 K Jul 6, 2023
Fergus Fleming Chief Technical Officer, Director $142 K Jul 6, 2023
Timothy J. Scannell Director $17.2 K Jul 1, 2023
Thomas H. Mclain President $14.8 K Jul 10, 2023
Erik Lium Director Jul 1, 2023
Joel R. Jung Interim Chief Financial Office Jun 11, 2024
Michael J. Donovan Chief Medical Officer Jul 6, 2023
Chirag R. Parikh Director Nov 20, 2023
Howard Doran JR Chief Business Officer Nov 20, 2023
Daniel J. Levangie Director Nov 20, 2023
Catherine Coste Director Nov 20, 2023

Recent Insider Transactions by Companies or Individuals for Renalytix plc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership